Maithani mukesh (65 résultats)

Etat : New.

Paperback. Etat : Brand New. 64 pages. 8.66x5.91x0.15 inches. In Stock.

Paperback. Etat : Brand New. 68 pages. 8.66x5.91x0.16 inches. In Stock.

Etat : New.

Taschenbuch. Etat : Neu. Regulations of Genotoxic Impurities in Pharmaceuticals | Mukesh Maithani (u. a.) | Taschenbuch | 68 S. | Englisch | 2018 | LAP LAMBERT Academic Publishing | EAN 9786139926947 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. …

Taschenbuch. Etat : Neu. Simultaneous Estimation of Drugs by RP-HPLC | SIMULTANEOUS ESTIMATION OF [.], OFLOXACIN, TINIDAZOLE AND ORNIDAZOLE BY REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY | Mukesh Maithani | Taschenbuch | 140 S. | Englisch | 2011 | LAP LAMBERT Academic Publishing | EAN 9783843375153 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.…

Etat : New. pp. XXII, 101 36 illus., 7 illus. in color. 1st ed. 2019 edition NO-PA16APR2015-KAP.

Etat : New.

Etat : New.

Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Reversed-phase high-performance liquid chromatography (RP-HPLC) has become the most widely used method for pharmaceutical analysis, as it ensures accuracy, specificity and reproducibility for the quantification of drugs, while avoiding interference from any of the excipients that are normally present in pharmaceutical dosage forms. This book presents a simple methodology for developing stability-indicating methods and offers a 'how-to guide' to creating novel stability-indicating methods using liquid chromatography. It provides the detailed information needed to devise a stability-indicating method for drug substances and drug products that comply with international regulatory guidelines. As such, it is a must-read for anyone engaged in analytical and bioanalytical chemistry: professionals at reference, test, and control laboratories; students and academics at research laboratories, and scientists working for chemical, pharmaceutical, and biotechnology companies.…

Taschenbuch. Etat : Neu. Development of Novel Stability Indicating Methods Using Liquid Chromatography | Mukesh Maithani (u. a.) | Taschenbuch | xxii | Englisch | 2020 | Springer | EAN 9789811387258 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Paperback. Etat : Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Paperback. Etat : New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

paperback. Etat : New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Taschenbuch. Etat : Neu. Réglementation des impuretés génotoxiques dans les produits pharmaceutiques | Mukesh Maithani (u. a.) | Taschenbuch | Französisch | 2023 | Editions Notre Savoir | EAN 9786205647608 | Verantwortliche Person für die EU: SIA OmniScriptum Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu.…

Etat : New.

Etat : New.

paperback. Etat : New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Taschenbuch. Etat : Neu. Regulamentos de Impurezas Genotóxicas em Produtos Farmacêuticos | Mukesh Maithani (u. a.) | Taschenbuch | Portugiesisch | 2023 | Edições Nosso Conhecimento | EAN 9786205647622 | Verantwortliche Person für die EU: SIA OmniScriptum Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu. …

Taschenbuch. Etat : Neu. Regolamentazione delle impurità genotossiche nei prodotti farmaceutici | Mukesh Maithani (u. a.) | Taschenbuch | Italienisch | 2023 | Edizioni Sapienza | EAN 9786205647615 | Verantwortliche Person für die EU: SIA OmniScriptum Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu. …

Taschenbuch. Etat : Neu. Vorschriften für genotoxische Verunreinigungen in Arzneimitteln | Mukesh Maithani (u. a.) | Taschenbuch | 60 S. | Deutsch | 2023 | Verlag Unser Wissen | EAN 9786205647585 | Verantwortliche Person für die EU: SIA OmniScriptum Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu. …

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Inborn metabolic disorders are rare, but the diseases with which they are associated often have a significant impact on development, growth, and long-term health of affected children. Early detection and intervention are very essential to avoiding disastrous consequences associated with these diseases. Hundreds of disorders have been described until now and there has been a considerable clinical overlap between certain inborn errors. Resulting from this fact, the definite diagnosis of inborn errors depends on enzyme assays or genetic tests. Especially during the recent years, significant achievements have been gained for the biochemical and genetic diagnosis of inborn errors. In addition, if detected and treated early, the clinical outcome for many inborn metabolic disorders can be favorable. Techniques such as tandem mass spectrometry and gas chromatography for biochemical diagnosis and microarrays and next-generation sequencing for the genetic diagnosis have enabled rapid and accurate diagnosis. This monograph provides a comprehensive detail of inborn metabolic disorders with history, etiology, pathogenesis, diagnostic tools, management and future prospective. 88 pp. Englisch.…

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The impurities in pharmaceuticals are superfluous chemicals that remain with the active pharmaceutical ingredients (APIs) or develop during formulation or upon aging of both pharmaceutical ingredients and formulation. The presence of these superfluous chemicals even in small amount may manipulate the safety and efficacy of pharmaceutical product. Some of these impurities also known as genotoxic impurities (GIs) could be mutagens or carcinogens and cause adverse effects on the human body even in trace amount. Starting materials, reagents, intermediates, by products, and degradation products are often found as impurities in active pharmaceutical ingredients. There are several regulatory guidelines and position papers focused on controlling the amount of impurities within specified limits. The present compilation gives an account of updated information about GIs and reviews the regulatory aspects for GIs in active pharmaceutical ingredients/drug formulations. A detailed discussion about control strategies in the context of GIs is also described precisely. 68 pp. Englisch.…

Etat : New. Print on Demand.

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Las impurezas en los productos farmacéuticos son sustancias químicas superfluas que permanecen con los ingredientes farmacéuticos activos (API) o se desarrollan durante la formulación o tras el envejecimiento tanto de los ingredientes farmacéuticos como de la formulación. La presencia de estas sustancias químicas superfluas, incluso en pequeñas cantidades, puede alterar la seguridad y eficacia del producto farmacéutico. Algunas de estas impurezas, también conocidas como impurezas genotóxicas (IG), podrían ser mutágenas o carcinógenas y causar efectos adversos en el cuerpo humano incluso en cantidades ínfimas. Los materiales de partida, reactivos, productos intermedios, subproductos y productos de degradación se encuentran a menudo como impurezas en los principios activos farmacéuticos. Existen varias directrices normativas y documentos de posición centrados en el control de la cantidad de impurezas dentro de los límites especificados. La presente compilación da cuenta de la información actualizada sobre las IG y revisa los aspectos regulatorios para las IG en los ingredientes farmacéuticos activos/formulaciones de medicamentos. También se describe con precisión un debate detallado sobre las estrategias de control en el contexto de las IG. 56 pp. Spanisch.…

Etat : New. PRINT ON DEMAND.

Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Microstylis muscifera is one of the important plants of Ashtawarga group. Department of AYUSH has suggested use of substitutes in formulations in absence of original plants however this option is being exploited by manufacturers rendering this precious plant in ignored condition. Hence it becomes important to highlight the therapeutic potentials of this plant in front of scientists so that a justified research is carried out on an important but ignored plant. A limited data with scientific evidences are available in modern literature/internet sources; whereas old texts show valuable evidences in regional languages or in Sanskrit. Hence real uses of the plant are not well understood by scientific fraternity. Purpose of this compilation is to bring all the available information of Microstylis muscifera at a single platform so as to enable scientists working on these plants to know the scientific clues available in ancient literature.…

Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Bansal ParveenDr.Parveen Bansal, Ph.D.(Biochemistry), FRSM, FICA(USA), Joint Director,Baba Farid University of Health Sciences, Faridkot with 23yrs experience represented India in 23rd Indian Scientific Expedition to Antarctica.In ad.…

Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Bansal ParveenDr.Parveen Bansal, Ph.D.(Biochemistry), FRSM, FICA(USA), Joint Director,Baba Farid University of Health Sciences, Faridkot with 23yrs experience represented India in 23rd Indian Scientific Expedition to Antarctica.In ad.…

Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Inborn metabolic disorders are rare, but the diseases with which they are associated often have a significant impact on development, growth, and long-term health of affected children. Early detection and intervention are very essential to avoiding disastrous consequences associated with these diseases. Hundreds of disorders have been described until now and there has been a considerable clinical overlap between certain inborn errors. Resulting from this fact, the definite diagnosis of inborn errors depends on enzyme assays or genetic tests. Especially during the recent years, significant achievements have been gained for the biochemical and genetic diagnosis of inborn errors. In addition, if detected and treated early, the clinical outcome for many inborn metabolic disorders can be favorable. Techniques such as tandem mass spectrometry and gas chromatography for biochemical diagnosis and microarrays and next-generation sequencing for the genetic diagnosis have enabled rapid and accurate diagnosis. This monograph provides a comprehensive detail of inborn metabolic disorders with history, etiology, pathogenesis, diagnostic tools, management and future prospective.…